Clinical trial
A Phase 2, Open-label, Prospective, Multicenter Study to Evaluate the Efficacy of Intravenous Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
NCT01923935 is registered in ClinicalTrials.gov with Chonnam National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Open-label, Prospective, Multicenter Study to Evaluate the Efficacy of Intravenous Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
- Lead sponsor
- Chonnam National University Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2013
- Completion date
- December 31, 2015
- Enrollment
- 105 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.